China Sinopharm "COVID-19 Vaccine 79.34% Efficacy"
![[Image source=Yonhap News]](http://www.asiae.co.kr/news/img_view.htm?img=2020121220430362174_1607773383.jpg)
[Asia Economy Reporter Jeon Jinyoung] Chinese pharmaceutical company Sinopharm announced that the preventive efficacy of its newly developed coronavirus disease (COVID-19) vaccine reaches 79.34%.
According to Huanqiu Shibao on the 30th, Sinopharm disclosed interim analysis data from its Phase 3 clinical trial results, stating that the current vaccine efficacy is at the 79.34% level.
Sinopharm also reported that the antibody positivity rate of the vaccine is 99.52%, indicating that most vaccinated individuals developed antibodies.
Hot Picks Today
Taking Annual Leave and Adding "Strike" to Profiles, "It Feels Like Samsung Has Collapsed"... Unsettled Internal Atmosphere
- There Is a Distinct Age When Physical Abilities Decline Rapidly... From What Age Do Strength and Endurance Drop?
- "One Comment Could Lead to a Report": 86% of Elementary Teachers Feel Anxious; Half Consider Resignation or Career Change
- "After Vowing to Become No. 1 Globally, Sudden Policy Brake Puts Companies’ Massive Investments at Risk"
- On Teacher's Day, a Student's Gifted Cake Had to Be Cut into 32 Pieces... Why?
This is about 15% lower than the preventive efficacy of the mRNA vaccines developed by the American pharmaceutical companies Moderna and Pfizer. Moderna and Pfizer showed preventive efficacies of 94.5% and 95%, respectively.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
